Company / Free Cash Flow per Share
Ovid Therapeutics Inc. Free Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.79
FY2025
5-year range
-$0.80 / $1.68
FY2022-FY2025
Trend
-21.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-0.79 in FY2025.
Remained stable around $-0.79 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 21.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.79 | -21.7% |
| FY2024 | -$0.65 | +19.1% |
| FY2023 | -$0.80 | -147.6% |
| FY2022 | $1.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026